Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Editas Medicine (EDIT)

Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Medicine labratory by gorodenkoff via iStock
1 Penny Stock to Grab Now for 183% Upside Potential Barchart - Thu Nov 7, 3:31PM CST

This biotech penny stock could more than triple, based on consensus forecasts.

VRTX : 450.37 (-0.19%)
EDIT : 2.37 (-1.66%)
BMY : 58.23 (+0.60%)
Editas Medicine to Participate in Upcoming Investor Conferences GlobeNewswire - Wed Nov 6, 8:00AM CST

EDIT : 2.37 (-1.66%)
Editas: Q3 Earnings Snapshot AP - Mon Nov 4, 6:36AM CST

Editas: Q3 Earnings Snapshot

EDIT : 2.37 (-1.66%)
Editas Medicine Announces Third Quarter 2024 Results and Business Updates GlobeNewswire - Mon Nov 4, 6:30AM CST

EDIT : 2.37 (-1.66%)
Editas Medicine Announces Progress Towards 2024 Goals, Including Achievement of In Vivo Preclinical Proof of Concept and Strategic Update GlobeNewswire - Tue Oct 22, 6:00AM CDT

EDIT : 2.37 (-1.66%)
Editas Medicine and Genevant Sciences to Collaborate to Develop Novel mRNA-LNP Gene Editing Therapeutics GlobeNewswire - Mon Oct 21, 3:30PM CDT

EDIT : 2.37 (-1.66%)
Editas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of Concept GlobeNewswire - Fri Oct 18, 3:01PM CDT

EDIT : 2.37 (-1.66%)
Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust GlobeNewswire - Thu Oct 3, 5:00PM CDT

EDIT : 2.37 (-1.66%)
Looking for Stock Bargains With Room to Run? Try This. Motley Fool - Wed Sep 11, 3:07PM CDT

Investing tips from Bill Mann, The Motley Fool's director of small-cap research.

WBA : 8.30 (+0.73%)
AAPL : 228.52 (-0.21%)
AMZN : 198.38 (-2.22%)
EXPE : 183.51 (+2.46%)
DENN : 6.39 (+1.91%)
CBRL : 47.64 (+2.74%)
JACK : 47.80 (+4.82%)
BJRI : 34.52 (+1.14%)
SABR : 3.67 (+1.94%)
EDIT : 2.37 (-1.66%)
CRSP : 46.29 (-2.05%)
DESP : 18.49 (+4.40%)
Editas: Q2 Earnings Snapshot AP - Wed Aug 7, 6:07AM CDT

Editas: Q2 Earnings Snapshot

EDIT : 2.37 (-1.66%)

Barchart Exclusives

2 Energy Dividend Stocks Yielding 6% to Pick Now Barchart - 14 minutes ago
These two have been favorites among income-focused investors due to their high and consistent distribution yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot